Skip to main content
The Doctor's Channel Logo

The ISM Content Hub Channel

ACTA Médica Portuguesa

Safety of a mRNA COVID-19 vaccine in patients with indolent systemic mastocytosis.

Gouveia J, Rodrigues MA, Fernandes I, Cabral R, Falcão H.

In this retrospective analysis, data suggest that patients with indolent systemic mastocytosis can be safely vaccinated against COVID-19, even when there is an increased risk of allergic reactions, with the use of pre-medication. Option 2: Learn about COVID-19 vaccinations for patients with indolent systemic mastocytosis.

Previous Article Next Article

Featured Videos in ISM Content Hub